Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

AIGISRx Envelope for Prevention of Infection Following Replacement With an Implantable Cardioverter-Defibrillator (ICD)
AIGISRx Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following Cardiac Rhythm Management Device Replacement With an Implantable Cardioverter-Defibrillator (ICD)
Status: Enrolling
Updated:  7/19/2011
Our Lady of Lourdes Hospital
mi
from
Sewell, NJ
AIGISRx Envelope for Prevention of Infection Following Replacement With an Implantable Cardioverter-Defibrillator (ICD)
AIGISRx Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following Cardiac Rhythm Management Device Replacement With an Implantable Cardioverter-Defibrillator (ICD)
Status: Enrolling
Updated: 7/19/2011
Our Lady of Lourdes Hospital
mi
from
Sewell, NJ
Click here to add this to my saved trials
AIGISRx Envelope for Prevention of Infection Following Replacement With an Implantable Cardioverter-Defibrillator (ICD)
AIGISRx Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following Cardiac Rhythm Management Device Replacement With an Implantable Cardioverter-Defibrillator (ICD)
Status: Enrolling
Updated:  7/19/2011
St. Luke's Roosevelt Hospital
mi
from
New York, NY
AIGISRx Envelope for Prevention of Infection Following Replacement With an Implantable Cardioverter-Defibrillator (ICD)
AIGISRx Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following Cardiac Rhythm Management Device Replacement With an Implantable Cardioverter-Defibrillator (ICD)
Status: Enrolling
Updated: 7/19/2011
St. Luke's Roosevelt Hospital
mi
from
New York, NY
Click here to add this to my saved trials
AIGISRx Envelope for Prevention of Infection Following Replacement With an Implantable Cardioverter-Defibrillator (ICD)
AIGISRx Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following Cardiac Rhythm Management Device Replacement With an Implantable Cardioverter-Defibrillator (ICD)
Status: Enrolling
Updated:  7/19/2011
Carolinas Medical Center Northeast
mi
from
Concord, NC
AIGISRx Envelope for Prevention of Infection Following Replacement With an Implantable Cardioverter-Defibrillator (ICD)
AIGISRx Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following Cardiac Rhythm Management Device Replacement With an Implantable Cardioverter-Defibrillator (ICD)
Status: Enrolling
Updated: 7/19/2011
Carolinas Medical Center Northeast
mi
from
Concord, NC
Click here to add this to my saved trials
AIGISRx Envelope for Prevention of Infection Following Replacement With an Implantable Cardioverter-Defibrillator (ICD)
AIGISRx Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following Cardiac Rhythm Management Device Replacement With an Implantable Cardioverter-Defibrillator (ICD)
Status: Enrolling
Updated:  7/19/2011
Frye Regional Medical Center
mi
from
Hickory, NC
AIGISRx Envelope for Prevention of Infection Following Replacement With an Implantable Cardioverter-Defibrillator (ICD)
AIGISRx Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following Cardiac Rhythm Management Device Replacement With an Implantable Cardioverter-Defibrillator (ICD)
Status: Enrolling
Updated: 7/19/2011
Frye Regional Medical Center
mi
from
Hickory, NC
Click here to add this to my saved trials
AIGISRx Envelope for Prevention of Infection Following Replacement With an Implantable Cardioverter-Defibrillator (ICD)
AIGISRx Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following Cardiac Rhythm Management Device Replacement With an Implantable Cardioverter-Defibrillator (ICD)
Status: Enrolling
Updated:  7/19/2011
Catholic Health Partners
mi
from
Youngstown, OH
AIGISRx Envelope for Prevention of Infection Following Replacement With an Implantable Cardioverter-Defibrillator (ICD)
AIGISRx Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following Cardiac Rhythm Management Device Replacement With an Implantable Cardioverter-Defibrillator (ICD)
Status: Enrolling
Updated: 7/19/2011
Catholic Health Partners
mi
from
Youngstown, OH
Click here to add this to my saved trials
AIGISRx Envelope for Prevention of Infection Following Replacement With an Implantable Cardioverter-Defibrillator (ICD)
AIGISRx Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following Cardiac Rhythm Management Device Replacement With an Implantable Cardioverter-Defibrillator (ICD)
Status: Enrolling
Updated:  7/19/2011
Doylestown Hospital
mi
from
Doylestown, PA
AIGISRx Envelope for Prevention of Infection Following Replacement With an Implantable Cardioverter-Defibrillator (ICD)
AIGISRx Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following Cardiac Rhythm Management Device Replacement With an Implantable Cardioverter-Defibrillator (ICD)
Status: Enrolling
Updated: 7/19/2011
Doylestown Hospital
mi
from
Doylestown, PA
Click here to add this to my saved trials
AIGISRx Envelope for Prevention of Infection Following Replacement With an Implantable Cardioverter-Defibrillator (ICD)
AIGISRx Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following Cardiac Rhythm Management Device Replacement With an Implantable Cardioverter-Defibrillator (ICD)
Status: Enrolling
Updated:  7/19/2011
Pinnacle Health Harrisburg Hospital
mi
from
Harrisburg, PA
AIGISRx Envelope for Prevention of Infection Following Replacement With an Implantable Cardioverter-Defibrillator (ICD)
AIGISRx Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following Cardiac Rhythm Management Device Replacement With an Implantable Cardioverter-Defibrillator (ICD)
Status: Enrolling
Updated: 7/19/2011
Pinnacle Health Harrisburg Hospital
mi
from
Harrisburg, PA
Click here to add this to my saved trials
AIGISRx Envelope for Prevention of Infection Following Replacement With an Implantable Cardioverter-Defibrillator (ICD)
AIGISRx Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following Cardiac Rhythm Management Device Replacement With an Implantable Cardioverter-Defibrillator (ICD)
Status: Enrolling
Updated:  7/19/2011
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
AIGISRx Envelope for Prevention of Infection Following Replacement With an Implantable Cardioverter-Defibrillator (ICD)
AIGISRx Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following Cardiac Rhythm Management Device Replacement With an Implantable Cardioverter-Defibrillator (ICD)
Status: Enrolling
Updated: 7/19/2011
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
AIGISRx Envelope for Prevention of Infection Following Replacement With an Implantable Cardioverter-Defibrillator (ICD)
AIGISRx Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following Cardiac Rhythm Management Device Replacement With an Implantable Cardioverter-Defibrillator (ICD)
Status: Enrolling
Updated:  7/19/2011
York Hospital
mi
from
York, PA
AIGISRx Envelope for Prevention of Infection Following Replacement With an Implantable Cardioverter-Defibrillator (ICD)
AIGISRx Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following Cardiac Rhythm Management Device Replacement With an Implantable Cardioverter-Defibrillator (ICD)
Status: Enrolling
Updated: 7/19/2011
York Hospital
mi
from
York, PA
Click here to add this to my saved trials
AIGISRx Envelope for Prevention of Infection Following Replacement With an Implantable Cardioverter-Defibrillator (ICD)
AIGISRx Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following Cardiac Rhythm Management Device Replacement With an Implantable Cardioverter-Defibrillator (ICD)
Status: Enrolling
Updated:  7/19/2011
Landmark Medical Center
mi
from
Woonsocket, RI
AIGISRx Envelope for Prevention of Infection Following Replacement With an Implantable Cardioverter-Defibrillator (ICD)
AIGISRx Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following Cardiac Rhythm Management Device Replacement With an Implantable Cardioverter-Defibrillator (ICD)
Status: Enrolling
Updated: 7/19/2011
Landmark Medical Center
mi
from
Woonsocket, RI
Click here to add this to my saved trials
AIGISRx Envelope for Prevention of Infection Following Replacement With an Implantable Cardioverter-Defibrillator (ICD)
AIGISRx Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following Cardiac Rhythm Management Device Replacement With an Implantable Cardioverter-Defibrillator (ICD)
Status: Enrolling
Updated:  7/19/2011
Stern Cardiovascular Foundation
mi
from
Germantown, TN
AIGISRx Envelope for Prevention of Infection Following Replacement With an Implantable Cardioverter-Defibrillator (ICD)
AIGISRx Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following Cardiac Rhythm Management Device Replacement With an Implantable Cardioverter-Defibrillator (ICD)
Status: Enrolling
Updated: 7/19/2011
Stern Cardiovascular Foundation
mi
from
Germantown, TN
Click here to add this to my saved trials
AIGISRx Envelope for Prevention of Infection Following Replacement With an Implantable Cardioverter-Defibrillator (ICD)
AIGISRx Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following Cardiac Rhythm Management Device Replacement With an Implantable Cardioverter-Defibrillator (ICD)
Status: Enrolling
Updated:  7/19/2011
University of TN Medical Center, Knoxville
mi
from
Knoxville, TN
AIGISRx Envelope for Prevention of Infection Following Replacement With an Implantable Cardioverter-Defibrillator (ICD)
AIGISRx Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following Cardiac Rhythm Management Device Replacement With an Implantable Cardioverter-Defibrillator (ICD)
Status: Enrolling
Updated: 7/19/2011
University of TN Medical Center, Knoxville
mi
from
Knoxville, TN
Click here to add this to my saved trials
AIGISRx Envelope for Prevention of Infection Following Replacement With an Implantable Cardioverter-Defibrillator (ICD)
AIGISRx Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following Cardiac Rhythm Management Device Replacement With an Implantable Cardioverter-Defibrillator (ICD)
Status: Enrolling
Updated:  7/19/2011
Texas Heart Institute - St. Luke's Episcopal Hospital
mi
from
Houston, TX
AIGISRx Envelope for Prevention of Infection Following Replacement With an Implantable Cardioverter-Defibrillator (ICD)
AIGISRx Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following Cardiac Rhythm Management Device Replacement With an Implantable Cardioverter-Defibrillator (ICD)
Status: Enrolling
Updated: 7/19/2011
Texas Heart Institute - St. Luke's Episcopal Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
AIGISRx Envelope for Prevention of Infection Following Replacement With an Implantable Cardioverter-Defibrillator (ICD)
AIGISRx Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following Cardiac Rhythm Management Device Replacement With an Implantable Cardioverter-Defibrillator (ICD)
Status: Enrolling
Updated:  7/19/2011
NE Methodist
mi
from
San Antonio, TX
AIGISRx Envelope for Prevention of Infection Following Replacement With an Implantable Cardioverter-Defibrillator (ICD)
AIGISRx Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following Cardiac Rhythm Management Device Replacement With an Implantable Cardioverter-Defibrillator (ICD)
Status: Enrolling
Updated: 7/19/2011
NE Methodist
mi
from
San Antonio, TX
Click here to add this to my saved trials
AIGISRx Envelope for Prevention of Infection Following Replacement With an Implantable Cardioverter-Defibrillator (ICD)
AIGISRx Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following Cardiac Rhythm Management Device Replacement With an Implantable Cardioverter-Defibrillator (ICD)
Status: Enrolling
Updated:  7/19/2011
Aurora Health Care
mi
from
Milwaukee, WI
AIGISRx Envelope for Prevention of Infection Following Replacement With an Implantable Cardioverter-Defibrillator (ICD)
AIGISRx Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following Cardiac Rhythm Management Device Replacement With an Implantable Cardioverter-Defibrillator (ICD)
Status: Enrolling
Updated: 7/19/2011
Aurora Health Care
mi
from
Milwaukee, WI
Click here to add this to my saved trials
AIGISRx Envelope for Prevention of Infection Following Replacement With an Implantable Cardioverter-Defibrillator (ICD)
AIGISRx Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following Cardiac Rhythm Management Device Replacement With an Implantable Cardioverter-Defibrillator (ICD)
Status: Enrolling
Updated:  7/19/2011
The Wisconsin Heart Hospital
mi
from
Wauwatosa, WI
AIGISRx Envelope for Prevention of Infection Following Replacement With an Implantable Cardioverter-Defibrillator (ICD)
AIGISRx Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following Cardiac Rhythm Management Device Replacement With an Implantable Cardioverter-Defibrillator (ICD)
Status: Enrolling
Updated: 7/19/2011
The Wisconsin Heart Hospital
mi
from
Wauwatosa, WI
Click here to add this to my saved trials
Effects of Mitral Valve Repair With the Geoform Ring on Cardiomyopathy
Destiny Trial: Effects of Mitral Valve Annuloplasty With the Geoform Ring on Left Ventricular Geometry and Function in Patients With Cardiomyopathy
Status: Enrolling
Updated:  7/20/2011
Ohio State University
mi
from
Columbus, OH
Effects of Mitral Valve Repair With the Geoform Ring on Cardiomyopathy
Destiny Trial: Effects of Mitral Valve Annuloplasty With the Geoform Ring on Left Ventricular Geometry and Function in Patients With Cardiomyopathy
Status: Enrolling
Updated: 7/20/2011
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Helping People to Exercise Regularly
Helping People to Exercise Regularly
Status: Enrolling
Updated:  7/21/2011
Carnegie Mellon University
mi
from
Pittsburgh, PA
Helping People to Exercise Regularly
Helping People to Exercise Regularly
Status: Enrolling
Updated: 7/21/2011
Carnegie Mellon University
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Injection of Autologous CD34-Positive Cells for Critical Limb Ischemia
Injection of Autologous CD34-Positive Cells for Improved Symptomatic Relief and Ischemic Wound Healing in Subjects With Moderate or High-Risk Critical Limb Ischemia
Status: Enrolling
Updated:  7/21/2011
Cardiology PC
mi
from
Birmingham, AL
Injection of Autologous CD34-Positive Cells for Critical Limb Ischemia
Injection of Autologous CD34-Positive Cells for Improved Symptomatic Relief and Ischemic Wound Healing in Subjects With Moderate or High-Risk Critical Limb Ischemia
Status: Enrolling
Updated: 7/21/2011
Cardiology PC
mi
from
Birmingham, AL
Click here to add this to my saved trials
Injection of Autologous CD34-Positive Cells for Critical Limb Ischemia
Injection of Autologous CD34-Positive Cells for Improved Symptomatic Relief and Ischemic Wound Healing in Subjects With Moderate or High-Risk Critical Limb Ischemia
Status: Enrolling
Updated:  7/21/2011
Florida Research Network LLC
mi
from
Gainsville, FL
Injection of Autologous CD34-Positive Cells for Critical Limb Ischemia
Injection of Autologous CD34-Positive Cells for Improved Symptomatic Relief and Ischemic Wound Healing in Subjects With Moderate or High-Risk Critical Limb Ischemia
Status: Enrolling
Updated: 7/21/2011
Florida Research Network LLC
mi
from
Gainsville, FL
Click here to add this to my saved trials
Injection of Autologous CD34-Positive Cells for Critical Limb Ischemia
Injection of Autologous CD34-Positive Cells for Improved Symptomatic Relief and Ischemic Wound Healing in Subjects With Moderate or High-Risk Critical Limb Ischemia
Status: Enrolling
Updated:  7/21/2011
Orlando Regional Medical Center
mi
from
Orlando, FL
Injection of Autologous CD34-Positive Cells for Critical Limb Ischemia
Injection of Autologous CD34-Positive Cells for Improved Symptomatic Relief and Ischemic Wound Healing in Subjects With Moderate or High-Risk Critical Limb Ischemia
Status: Enrolling
Updated: 7/21/2011
Orlando Regional Medical Center
mi
from
Orlando, FL
Click here to add this to my saved trials
Injection of Autologous CD34-Positive Cells for Critical Limb Ischemia
Injection of Autologous CD34-Positive Cells for Improved Symptomatic Relief and Ischemic Wound Healing in Subjects With Moderate or High-Risk Critical Limb Ischemia
Status: Enrolling
Updated:  7/21/2011
Northwestern University
mi
from
Chicago, IL
Injection of Autologous CD34-Positive Cells for Critical Limb Ischemia
Injection of Autologous CD34-Positive Cells for Improved Symptomatic Relief and Ischemic Wound Healing in Subjects With Moderate or High-Risk Critical Limb Ischemia
Status: Enrolling
Updated: 7/21/2011
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Injection of Autologous CD34-Positive Cells for Critical Limb Ischemia
Injection of Autologous CD34-Positive Cells for Improved Symptomatic Relief and Ischemic Wound Healing in Subjects With Moderate or High-Risk Critical Limb Ischemia
Status: Enrolling
Updated:  7/21/2011
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Injection of Autologous CD34-Positive Cells for Critical Limb Ischemia
Injection of Autologous CD34-Positive Cells for Improved Symptomatic Relief and Ischemic Wound Healing in Subjects With Moderate or High-Risk Critical Limb Ischemia
Status: Enrolling
Updated: 7/21/2011
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Click here to add this to my saved trials
Injection of Autologous CD34-Positive Cells for Critical Limb Ischemia
Injection of Autologous CD34-Positive Cells for Improved Symptomatic Relief and Ischemic Wound Healing in Subjects With Moderate or High-Risk Critical Limb Ischemia
Status: Enrolling
Updated:  7/21/2011
Massachusetts General Hospital
mi
from
Boston, MA
Injection of Autologous CD34-Positive Cells for Critical Limb Ischemia
Injection of Autologous CD34-Positive Cells for Improved Symptomatic Relief and Ischemic Wound Healing in Subjects With Moderate or High-Risk Critical Limb Ischemia
Status: Enrolling
Updated: 7/21/2011
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Injection of Autologous CD34-Positive Cells for Critical Limb Ischemia
Injection of Autologous CD34-Positive Cells for Improved Symptomatic Relief and Ischemic Wound Healing in Subjects With Moderate or High-Risk Critical Limb Ischemia
Status: Enrolling
Updated:  7/21/2011
Mount Sinai School of Medicine Division of Vascular Surgery
mi
from
New York, NY
Injection of Autologous CD34-Positive Cells for Critical Limb Ischemia
Injection of Autologous CD34-Positive Cells for Improved Symptomatic Relief and Ischemic Wound Healing in Subjects With Moderate or High-Risk Critical Limb Ischemia
Status: Enrolling
Updated: 7/21/2011
Mount Sinai School of Medicine Division of Vascular Surgery
mi
from
New York, NY
Click here to add this to my saved trials
Injection of Autologous CD34-Positive Cells for Critical Limb Ischemia
Injection of Autologous CD34-Positive Cells for Improved Symptomatic Relief and Ischemic Wound Healing in Subjects With Moderate or High-Risk Critical Limb Ischemia
Status: Enrolling
Updated:  7/21/2011
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Injection of Autologous CD34-Positive Cells for Critical Limb Ischemia
Injection of Autologous CD34-Positive Cells for Improved Symptomatic Relief and Ischemic Wound Healing in Subjects With Moderate or High-Risk Critical Limb Ischemia
Status: Enrolling
Updated: 7/21/2011
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Injection of Autologous CD34-Positive Cells for Critical Limb Ischemia
Injection of Autologous CD34-Positive Cells for Improved Symptomatic Relief and Ischemic Wound Healing in Subjects With Moderate or High-Risk Critical Limb Ischemia
Status: Enrolling
Updated:  7/21/2011
University Hospitals of Cleveland / Case Medical Center
mi
from
Cleveland, OH
Injection of Autologous CD34-Positive Cells for Critical Limb Ischemia
Injection of Autologous CD34-Positive Cells for Improved Symptomatic Relief and Ischemic Wound Healing in Subjects With Moderate or High-Risk Critical Limb Ischemia
Status: Enrolling
Updated: 7/21/2011
University Hospitals of Cleveland / Case Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Injection of Autologous CD34-Positive Cells for Critical Limb Ischemia
Injection of Autologous CD34-Positive Cells for Improved Symptomatic Relief and Ischemic Wound Healing in Subjects With Moderate or High-Risk Critical Limb Ischemia
Status: Enrolling
Updated:  7/21/2011
University of Utah-Vascular Surgery Division
mi
from
Salt Lake City, UT
Injection of Autologous CD34-Positive Cells for Critical Limb Ischemia
Injection of Autologous CD34-Positive Cells for Improved Symptomatic Relief and Ischemic Wound Healing in Subjects With Moderate or High-Risk Critical Limb Ischemia
Status: Enrolling
Updated: 7/21/2011
University of Utah-Vascular Surgery Division
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Injection of Autologous CD34-Positive Cells for Critical Limb Ischemia
Injection of Autologous CD34-Positive Cells for Improved Symptomatic Relief and Ischemic Wound Healing in Subjects With Moderate or High-Risk Critical Limb Ischemia
Status: Enrolling
Updated:  7/21/2011
Swedish Medical Center
mi
from
Seattle, WA
Injection of Autologous CD34-Positive Cells for Critical Limb Ischemia
Injection of Autologous CD34-Positive Cells for Improved Symptomatic Relief and Ischemic Wound Healing in Subjects With Moderate or High-Risk Critical Limb Ischemia
Status: Enrolling
Updated: 7/21/2011
Swedish Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Injection of Autologous CD34-Positive Cells for Critical Limb Ischemia
Injection of Autologous CD34-Positive Cells for Improved Symptomatic Relief and Ischemic Wound Healing in Subjects With Moderate or High-Risk Critical Limb Ischemia
Status: Enrolling
Updated:  7/21/2011
Comprehensive Cardiovascular Care St. Luke's Medical Center
mi
from
Milwaukee, WI
Injection of Autologous CD34-Positive Cells for Critical Limb Ischemia
Injection of Autologous CD34-Positive Cells for Improved Symptomatic Relief and Ischemic Wound Healing in Subjects With Moderate or High-Risk Critical Limb Ischemia
Status: Enrolling
Updated: 7/21/2011
Comprehensive Cardiovascular Care St. Luke's Medical Center
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Inflammation and Risk Prediction in Patients With Abdominal Aortic Aneurysm
Inflammation and Risk Prediction in Patients With Abdominal Aortic Aneurysm
Status: Enrolling
Updated:  7/25/2011
Vanderbilt University Medical Center
mi
from
Nashville, TN
Inflammation and Risk Prediction in Patients With Abdominal Aortic Aneurysm
Inflammation and Risk Prediction in Patients With Abdominal Aortic Aneurysm
Status: Enrolling
Updated: 7/25/2011
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Submucosal Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)
Submucosal Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)
Status: Enrolling
Updated:  7/25/2011
University of California, San Diego
mi
from
San Diego, CA
Submucosal Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)
Submucosal Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)
Status: Enrolling
Updated: 7/25/2011
University of California, San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
Circulating Adenosine Levels Before and After Intravenous (IV) Persantine
Circulating Adenosine Levels Before and After Intravenous (IV) Persantine
Status: Enrolling
Updated:  7/26/2011
University of Connecticut Health Center
mi
from
Farmington, CT
Circulating Adenosine Levels Before and After Intravenous (IV) Persantine
Circulating Adenosine Levels Before and After Intravenous (IV) Persantine
Status: Enrolling
Updated: 7/26/2011
University of Connecticut Health Center
mi
from
Farmington, CT
Click here to add this to my saved trials
Scripps Evaluation of Antiplatelet Therapies for Intermediate Duration With the Endeavor Stent (Seaside)
A Clinical Evaluation of Dual Antiplatelet Therapy Duration Following Treatment With the Medtronic Endeavor Zotarolimus-eluting Coronary Stent
Status: Enrolling
Updated:  7/26/2011
Scripps Clinic
mi
from
La Jolla, CA
Scripps Evaluation of Antiplatelet Therapies for Intermediate Duration With the Endeavor Stent (Seaside)
A Clinical Evaluation of Dual Antiplatelet Therapy Duration Following Treatment With the Medtronic Endeavor Zotarolimus-eluting Coronary Stent
Status: Enrolling
Updated: 7/26/2011
Scripps Clinic
mi
from
La Jolla, CA
Click here to add this to my saved trials
Inhaled Iloprost as an Adjunct to Inhaled Nitric Oxide in Pediatric Critical Care Patients
A Randomized, Double Blind, Placebo-controlled Pilot Study of the Safety and Effective Dosing of Inhaled Iloprost in Pediatric Patients With Pulmonary Hypertension Treated With Inhaled Nitric Oxide
Status: Enrolling
Updated:  7/29/2011
Seattle Children's Hospital
mi
from
Seattle, WA
Inhaled Iloprost as an Adjunct to Inhaled Nitric Oxide in Pediatric Critical Care Patients
A Randomized, Double Blind, Placebo-controlled Pilot Study of the Safety and Effective Dosing of Inhaled Iloprost in Pediatric Patients With Pulmonary Hypertension Treated With Inhaled Nitric Oxide
Status: Enrolling
Updated: 7/29/2011
Seattle Children's Hospital
mi
from
Seattle, WA
Click here to add this to my saved trials
Acute Coronary Syndrome and Care-Seeking Delay: A Web Based Behavioral Study
Acute Coronary Syndrome and Care-Seeking Delay: A Web Based Behavioral Study
Status: Enrolling
Updated:  7/29/2011
Yale University School of Nursing
mi
from
New Haven, CT
Acute Coronary Syndrome and Care-Seeking Delay: A Web Based Behavioral Study
Acute Coronary Syndrome and Care-Seeking Delay: A Web Based Behavioral Study
Status: Enrolling
Updated: 7/29/2011
Yale University School of Nursing
mi
from
New Haven, CT
Click here to add this to my saved trials
Catheter Ablation Versus Amiodarone for Shock Prophylaxis in Defibrillator Patients With Ventricular Tachycardia
Catheter Ablation Versus Amiodarone for Shock Prophylaxis in Defibrillator Patients With Ventricular Tachycardia: A Multi-center Randomized Trial
Status: Enrolling
Updated:  8/4/2011
Northwestern University
mi
from
Chicago, IL
Catheter Ablation Versus Amiodarone for Shock Prophylaxis in Defibrillator Patients With Ventricular Tachycardia
Catheter Ablation Versus Amiodarone for Shock Prophylaxis in Defibrillator Patients With Ventricular Tachycardia: A Multi-center Randomized Trial
Status: Enrolling
Updated: 8/4/2011
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Catheter Ablation Versus Amiodarone for Shock Prophylaxis in Defibrillator Patients With Ventricular Tachycardia
Catheter Ablation Versus Amiodarone for Shock Prophylaxis in Defibrillator Patients With Ventricular Tachycardia: A Multi-center Randomized Trial
Status: Enrolling
Updated:  8/4/2011
The Mayo Clinic
mi
from
Rochester, MN
Catheter Ablation Versus Amiodarone for Shock Prophylaxis in Defibrillator Patients With Ventricular Tachycardia
Catheter Ablation Versus Amiodarone for Shock Prophylaxis in Defibrillator Patients With Ventricular Tachycardia: A Multi-center Randomized Trial
Status: Enrolling
Updated: 8/4/2011
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Catheter Ablation Versus Amiodarone for Shock Prophylaxis in Defibrillator Patients With Ventricular Tachycardia
Catheter Ablation Versus Amiodarone for Shock Prophylaxis in Defibrillator Patients With Ventricular Tachycardia: A Multi-center Randomized Trial
Status: Enrolling
Updated:  8/4/2011
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Catheter Ablation Versus Amiodarone for Shock Prophylaxis in Defibrillator Patients With Ventricular Tachycardia
Catheter Ablation Versus Amiodarone for Shock Prophylaxis in Defibrillator Patients With Ventricular Tachycardia: A Multi-center Randomized Trial
Status: Enrolling
Updated: 8/4/2011
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Catheter Ablation Versus Amiodarone for Shock Prophylaxis in Defibrillator Patients With Ventricular Tachycardia
Catheter Ablation Versus Amiodarone for Shock Prophylaxis in Defibrillator Patients With Ventricular Tachycardia: A Multi-center Randomized Trial
Status: Enrolling
Updated:  8/4/2011
Texas Cardiac Arrhythmia Research Foundation
mi
from
Austin, TX
Catheter Ablation Versus Amiodarone for Shock Prophylaxis in Defibrillator Patients With Ventricular Tachycardia
Catheter Ablation Versus Amiodarone for Shock Prophylaxis in Defibrillator Patients With Ventricular Tachycardia: A Multi-center Randomized Trial
Status: Enrolling
Updated: 8/4/2011
Texas Cardiac Arrhythmia Research Foundation
mi
from
Austin, TX
Click here to add this to my saved trials
Catheter Ablation Versus Amiodarone for Shock Prophylaxis in Defibrillator Patients With Ventricular Tachycardia
Catheter Ablation Versus Amiodarone for Shock Prophylaxis in Defibrillator Patients With Ventricular Tachycardia: A Multi-center Randomized Trial
Status: Enrolling
Updated:  8/4/2011
University of Virginia Health System
mi
from
Charlottesville, VA
Catheter Ablation Versus Amiodarone for Shock Prophylaxis in Defibrillator Patients With Ventricular Tachycardia
Catheter Ablation Versus Amiodarone for Shock Prophylaxis in Defibrillator Patients With Ventricular Tachycardia: A Multi-center Randomized Trial
Status: Enrolling
Updated: 8/4/2011
University of Virginia Health System
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Catheter Ablation Versus Amiodarone for Shock Prophylaxis in Defibrillator Patients With Ventricular Tachycardia
Catheter Ablation Versus Amiodarone for Shock Prophylaxis in Defibrillator Patients With Ventricular Tachycardia: A Multi-center Randomized Trial
Status: Enrolling
Updated:  8/4/2011
Hamilton Health Sciences
mi
from
Hamilton,
Catheter Ablation Versus Amiodarone for Shock Prophylaxis in Defibrillator Patients With Ventricular Tachycardia
Catheter Ablation Versus Amiodarone for Shock Prophylaxis in Defibrillator Patients With Ventricular Tachycardia: A Multi-center Randomized Trial
Status: Enrolling
Updated: 8/4/2011
Hamilton Health Sciences
mi
from
Hamilton,
Click here to add this to my saved trials
A Study of the Safety and Efficacy of Injectable Thymosin Beta 4 for Treating Acute Myocardial Infarction
A Randomized, Double-blind, Placebo-Controlled, Study of the Safety and Efficacy of RGN-352 in Subjects With an Acute ST Elevation Myocardial Infarction (STEMI) After Occlusion of the Proximal Left Anterior Descending Coronary Artery
Status: Enrolling
Updated:  8/8/2011
St. Vincent Indianapolis Hospital
mi
from
Indianapolis, IN
A Study of the Safety and Efficacy of Injectable Thymosin Beta 4 for Treating Acute Myocardial Infarction
A Randomized, Double-blind, Placebo-Controlled, Study of the Safety and Efficacy of RGN-352 in Subjects With an Acute ST Elevation Myocardial Infarction (STEMI) After Occlusion of the Proximal Left Anterior Descending Coronary Artery
Status: Enrolling
Updated: 8/8/2011
St. Vincent Indianapolis Hospital
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Study of the Safety and Efficacy of Injectable Thymosin Beta 4 for Treating Acute Myocardial Infarction
A Randomized, Double-blind, Placebo-Controlled, Study of the Safety and Efficacy of RGN-352 in Subjects With an Acute ST Elevation Myocardial Infarction (STEMI) After Occlusion of the Proximal Left Anterior Descending Coronary Artery
Status: Enrolling
Updated:  8/8/2011
The Valley Hospital
mi
from
Ridgewood, NJ
A Study of the Safety and Efficacy of Injectable Thymosin Beta 4 for Treating Acute Myocardial Infarction
A Randomized, Double-blind, Placebo-Controlled, Study of the Safety and Efficacy of RGN-352 in Subjects With an Acute ST Elevation Myocardial Infarction (STEMI) After Occlusion of the Proximal Left Anterior Descending Coronary Artery
Status: Enrolling
Updated: 8/8/2011
The Valley Hospital
mi
from
Ridgewood, NJ
Click here to add this to my saved trials
Aliskiren Effect on Plaque Progression In Established Atherosclerosis Using High Resolution 3D MRI (ALPINE)
Aliskiren Effect on Plaque Progression In Established Atherosclerosis Using High Resolution 3D MRI (ALPINE): A Double Blind Placebo Controlled Trial
Status: Enrolling
Updated:  8/15/2011
Ohio State University
mi
from
Columbus, OH
Aliskiren Effect on Plaque Progression In Established Atherosclerosis Using High Resolution 3D MRI (ALPINE)
Aliskiren Effect on Plaque Progression In Established Atherosclerosis Using High Resolution 3D MRI (ALPINE): A Double Blind Placebo Controlled Trial
Status: Enrolling
Updated: 8/15/2011
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Relation of Diet to Heart Disease Risk Factors in Children
Relation of Diet to Heart Disease Risk Factors in Children
Status: Enrolling
Updated:  8/15/2011
Children's Hospital and Research Center Oakland
mi
from
Oakland, CA
Relation of Diet to Heart Disease Risk Factors in Children
Relation of Diet to Heart Disease Risk Factors in Children
Status: Enrolling
Updated: 8/15/2011
Children's Hospital and Research Center Oakland
mi
from
Oakland, CA
Click here to add this to my saved trials
Coronary Computed Tomography (CT) Angiography Versus Standard Therapy in the Emergency Room
64 Slice Coronary CT Angiography vs. Standard Therapy in the Emergency Room: Determining Cost-effectiveness and Predicting Clinical Outcome in Patients With Low and Moderate Risk for Acute Coronary Syndrome.
Status: Enrolling
Updated:  8/30/2011
University of Michigan Health System
mi
from
Ann Arbor, MI
Coronary Computed Tomography (CT) Angiography Versus Standard Therapy in the Emergency Room
64 Slice Coronary CT Angiography vs. Standard Therapy in the Emergency Room: Determining Cost-effectiveness and Predicting Clinical Outcome in Patients With Low and Moderate Risk for Acute Coronary Syndrome.
Status: Enrolling
Updated: 8/30/2011
University of Michigan Health System
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Monitoring and Adjustment of Medication Therapy for Patients With Heart Disease
A Prospective Evaluation of a Medication Therapy Management Clinic Versus Usual Medical Care in Patients Post Acute Coronary Syndrome: The MUMPS Study
Status: Enrolling
Updated:  8/31/2011
VA Tennessee Valley Healthcare System
mi
from
Nashville, TN
Monitoring and Adjustment of Medication Therapy for Patients With Heart Disease
A Prospective Evaluation of a Medication Therapy Management Clinic Versus Usual Medical Care in Patients Post Acute Coronary Syndrome: The MUMPS Study
Status: Enrolling
Updated: 8/31/2011
VA Tennessee Valley Healthcare System
mi
from
Nashville, TN
Click here to add this to my saved trials
Evaluate Heart Failure Patients With Specially Designed Patient Adherence and Monitoring Software on Standard Mobile Devices
Remote Monitoring of Heart Failure Patients (REMOTE-HF-1) Study - to Assess Utility of a Mobile Device for Improved Management of At-risk Patients
Status: Archived
Updated:  9/7/2011
Winthrop University Hospital
mi
from
Mineola, NY
Evaluate Heart Failure Patients With Specially Designed Patient Adherence and Monitoring Software on Standard Mobile Devices
Remote Monitoring of Heart Failure Patients (REMOTE-HF-1) Study - to Assess Utility of a Mobile Device for Improved Management of At-risk Patients
Status: Archived
Updated: 9/7/2011
Winthrop University Hospital
mi
from
Mineola, NY
Evaluate Heart Failure Patients With Specially Designed Patient Adherence and Monitoring Software on Standard Mobile Devices
Remote Monitoring of Heart Failure Patients (REMOTE-HF-1) Study - to Assess Utility of a Mobile Device for Improved Management of At-risk Patients
Status: Archived
Updated:  9/7/2011
Saint Francis Hospital
mi
from
Roslyn, NY
Evaluate Heart Failure Patients With Specially Designed Patient Adherence and Monitoring Software on Standard Mobile Devices
Remote Monitoring of Heart Failure Patients (REMOTE-HF-1) Study - to Assess Utility of a Mobile Device for Improved Management of At-risk Patients
Status: Archived
Updated: 9/7/2011
Saint Francis Hospital
mi
from
Roslyn, NY